Pim-1 and Pim-2 are frequently overexpressed in hematological malignancies, such as AML, chronic myeloid leukemia, and multiple myeloma, and implicated in their pathogenesis through various mechanisms, including upregulation of the mTORC1 pathway [16, 24]. This evidence concerns the gene PIM1 and plasma cell myeloma.